Chronic nicotine attenuates behavioral and synaptic plasticity impairments in a streptozotocin model of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuroscience

• Publication date

  2017-06-14

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuroscience.2017.04.011PMID 28433649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Separate elements of episodic memory subserved by distinct hippocampal–prefrontal connections

  2017cited by this paper
• The persistence of long‐term potentiation in the projection from ventral hippocampus to medial prefrontal cortex in awake rats

  2016cited by this paper
• The frequency of spontaneous seizures in rats correlates with alterations in sensorimotor gating, spatial working memory, and parvalbumin expression throughout limbic regions.

  2016cited by this paper
• Coordinated Excitation and Inhibition of Prefrontal Ensembles during Awake Hippocampal Sharp-Wave Ripple Events.

  2016cited by this paper
• Hippocampo-cortical coupling mediates memory consolidation during sleep

  2016cited by this paper
• Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer’s disease

  2015influential reference
• Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism

  2015cited by this paper
• The metabolism hypothesis of Alzheimer’s disease: from the concept of central insulin resistance and associated consequences to insulin therapy

  2015cited by this paper
• Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.

  2015cited by this paper
• Increased frequency of hippocampal sclerosis ILAE type 2 in patients with mesial temporal lobe epilepsy with normal episodic memory.

  2015cited by this paper
• Hippocampal-prefrontal input supports spatial encoding in working memory

  2015cited by this paper
• Modulation of hippocampus-prefrontal cortex synaptic transmission and disruption of executive cognitive functions by MK-801.

  2015cited by this paper
• Therapeutics of Alzheimer's disease: Past, present and future.

  2014cited by this paper
• Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning.

  2014influential reference
• The synaptic plasticity and memory hypothesis: encoding, storage and persistence

  2014cited by this paper
• Brain metabolic dysfunction at the core of Alzheimer's disease.

  2014cited by this paper
• Hippocampal expression of heat shock proteins in mesial temporal lobe epilepsy with psychiatric comorbidities and their relation to seizure outcome

  2014cited by this paper
• Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.

  2014cited by this paper
• Magnesium Protects Cognitive Functions and Synaptic Plasticity in Streptozotocin-Induced Sporadic Alzheimer’s Model

  2014cited by this paper
• NMDA receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus-prefrontal cortex pathway in vivo: correlation with γ oscillations.

  2013cited by this paper
• Investigations into the involvement of NMDA mechanisms in recognition memory

  2013cited by this paper
• Caffeine Consumption Prevents Memory Impairment, Neuronal Damage, and Adenosine A2A Receptors Upregulation in the Hippocampus of a Rat Model of Sporadic Dementia

  2013cited by this paper
• Nicotinic acetylcholine receptors controlling attention: behavior, circuits and sensitivity to disruption by nicotine.

  2013influential reference
• Age-Dependent Modulation of Synaptic Plasticity and Insulin Mimetic Effect of Lipoic Acid on a Mouse Model of Alzheimer’s Disease

  2013cited by this paper
• Functional structure of the intermediate and ventral hippocampo-prefrontal pathway in the prefrontal convergent system.

  2013cited by this paper
• Neurotrophins in mesial temporal lobe epilepsy with and without psychiatric comorbidities.

  2013cited by this paper
• Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex.

  2013cited by this paper
• Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer’s disease

  2012cited by this paper
• Early Presynaptic and Postsynaptic Calcium Signaling Abnormalities Mask Underlying Synaptic Depression in Presymptomatic Alzheimer's Disease Mice

  2012cited by this paper
• Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin.

  2012cited by this paper
• Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampus.

  2012cited by this paper
• α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?

  2012cited by this paper
• A Non-transgenic Mouse Model (icv-STZ Mouse) of Alzheimer’s Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse)

  2012cited by this paper
• α7-Nicotinic receptors and cognition.

  2012cited by this paper
• Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease

  2012cited by this paper
• Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents.

  2012cited by this paper
• The cholinergic system in aging and neuronal degeneration.

  2011cited by this paper
• Revisiting the cholinergic hypothesis in the development of Alzheimer's disease.

  2011cited by this paper
• Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study

  2011cited by this paper
• Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.

  2011cited by this paper
• ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor.

  2011cited by this paper
• Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model.

  2011cited by this paper
• Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.

  2011cited by this paper
• Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP.

  2011cited by this paper
• Intensification of long-term memory deficit by chronic stress and prevention by nicotine in a rat model of Alzheimer's disease.

  2010cited by this paper
• Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease.

  2010cited by this paper
• Nicotine addiction and nicotinic receptors: lessons from genetically modified mice

  2010cited by this paper
• Modeling Sporadic Alzheimer's Disease: The Insulin Resistant Brain State Generates Multiple Long-Term Morphobiological Abnormalities Including Hyperphosphorylated Tau Protein and Amyloid-β

  2009cited by this paper
• Mechanisms of Neuroprotective Effects of Nicotine and Acetylcholinesterase Inhibitors: Role of α4 and α7 Receptors in Neuroprotection

  2009cited by this paper
• Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.

  2009cited by this paper
• Synaptic degeneration in Alzheimer’s disease

  2009cited by this paper
• A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits.

  2009cited by this paper
• Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms

  2008cited by this paper
• Mesial temporal lobe epilepsy: Clinical and neuropathologic findings of familial and sporadic forms

  2008cited by this paper
• HE LATE-PHASE OF LONG-TERM POTENTIATION IN THE IPPOCAMPAL – PREFRONTAL CORTEX PATHWAY OF RATS IN VIVO : POSSIBLE INVOLVEMENT OF MONOAMINERGIC SYSTEMS

  2008cited by this paper
• Neurobiology of nicotine dependence

  2008cited by this paper
• Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine

  2008cited by this paper
• Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.

  2007cited by this paper
• Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

  2007cited by this paper
• Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein.

  2007cited by this paper
• Sensitization to nicotine: how the animal literature might inform future human research.

  2007cited by this paper
• Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats.

  2007cited by this paper
• Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

  2007cited by this paper
• Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'

  2006cited by this paper
• The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease

  2006cited by this paper
• Effect of Subchronic Treatment of Memantine, Galantamine, and Nicotine in the Brain of Tg2576 (APPswe) Transgenic Mice

  2006cited by this paper
• Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease

  2006cited by this paper
• Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

  2006cited by this paper
• Nicotine attenuates β‐amyloid peptide‐induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures

  2004cited by this paper
• Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.

  2004cited by this paper
• Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal Cortex

  2003cited by this paper
• The Role of Insulin Resistance in the Pathogenesis of Alzheimer’s Disease

  2003cited by this paper
• Nicotinic receptors in aging and dementia.

  2002cited by this paper
• Nicotine lowers the secretion of the Alzheimer's amyloid β-protein precursor that contains amyloid β-peptide in rat

  2002cited by this paper
• The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update

  2002cited by this paper
• Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

  2002cited by this paper
• Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus.

  2001cited by this paper
• Plasticity at hippocampal to prefrontal cortex synapses: Dual roles in working memory and consolidation

  2000cited by this paper
• On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

  2000cited by this paper
• Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis.

  1999cited by this paper
• Induction of stable long‐term depression in vivo in the hippocampal–prefrontal cortex pathway

  1999cited by this paper
• Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

  1998influential reference
• Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

  1998cited by this paper
• Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease

  1998cited by this paper
• Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.

  1995cited by this paper
• Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin.

  1993cited by this paper
• Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium

  1993cited by this paper
• A synaptic model of memory: long-term potentiation in the hippocampus

  1993cited by this paper
• Long-term potentiation in the prefrontal cortex following stimulation of the hippocampal CA1/subicular region.

  1990cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• Estimation of nuclear population from microtome sections

  1946cited by this paper

• Alkaloids and flavonoids of Solanaceae: Mechanisms of action in neurodegenerative diseases.

  2026cites this paper
• Chronic nicotine enhances object recognition memory via inducing long-term potentiation in the medial prefrontal cortex in mice.

  2025cites this paper
• Age- and Genotype-Dependent Effects of Chronic Nicotine on Presenilin1/2 Double Knockout Mice: From Behavior to Molecular Pathways.

  2025cites this paper
• The Footprint of CHASERR as a Potential Culprit in Alzheimer's Disease Patients: An In-Silico-Experimental Study.

  2025cites this paper
• Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles

  2024cites this paper
• Role of alpha-7 nicotinic acetylcholine receptor down-regulation in cyclic nucleotide reduction in memory-related brain regions of Alzheimer’s rats

  2024cites this paper
• Hippocampal acetylcholinesterase activation induced by streptozotocin in mice is protected by an organotellurium compound without evidence of toxicity.

  2024cites this paper
• Intracranial self-stimulation reverses impaired spatial learning and regulates serum microRNA levels in a streptozotocin-induced rat model of Alzheimer disease

  2024cites this paper
• Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles

  2023cites this paper
• Addictive drugs modify neurogenesis, synaptogenesis and synaptic plasticity to impair memory formation through neurotransmitter imbalances and signaling dysfunction.

  2023cites this paper
• Nicotine's effect on cognition, a friend or foe?

  2023cites this paper
• Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease

  2023cites this paper
• Nicotine depresses facial stimulation-evoked molecular layer interneuron-Purkinje cell synaptic transmission via α7 nicotinic acetylcholine receptors in mouse cerebellar cortex.

  2022cites this paper
• Biologically Active Compounds Present in Tobacco Smoke: Potential Interactions Between Smoking and Mental Health

  2022cites this paper
• CREB1K292 and HINFPK330 as Putative Common Therapeutic Targets in Alzheimer’s and Parkinson’s Disease

  2021cites this paper
• Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies

  2021cites this paper
• Alpha7 Nicotinic Acetylcholine Receptor Down Regulation Impairs Mitochondrial Function in Streptozotocin-induced Sporadic Alzheimer's Disease Model in Rats

  2021cites this paper
• Metabolomics analysis provides new insights into the medicinal value of flavonoids in tobacco leaves.

  2021cites this paper
• Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders

  2021cites this paper
• Hormesis and embryonic stem cells.

  2021cites this paper
• Neurotoxic effects of high-dose piperine on hippocampal synaptic transmission and synaptic plasticity in a rat model of memory impairment.

  2020cites this paper
• The functional effects of piperine and piperine plus donepezil on hippocampal synaptic plasticity impairment in rat model of Alzheimer's disease.

  2020cites this paper
• Critical Review of the Alzheimer’s Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?

  2020influential citation
• Long-term potentiation prevents ketamine-induced aberrant neurophysiological dynamics in the hippocampus-prefrontal cortex pathway in vivo

  2019cites this paper
• Iron Pathophysiology in Alzheimer's Diseases.

  2019cites this paper
• Work 5-2019 Sleep and Circadian Rhythm Dysfunction in Alzheimer ’ s Disease

  2019cites this paper
• Sleep and Circadian Rhythm Dysfunction in Alzheimer’s Disease

  2019cites this paper
• Neurobehavioral effects of selected tobacco constituents in rodents following subchronic administration.

  2019cites this paper
• Nicotine promotes the differentiation of C2C12 myoblasts and improves skeletal muscle regeneration in obese mice.

  2019cites this paper
• Lithium modulates the muscarinic facilitation of synaptic plasticity and theta‐gamma coupling in the hippocampal‐prefrontal pathway

  2018cites this paper
• Sulforaphane Alleviates Lipopolysaccharide-induced Spatial Learning and Memory Dysfunction in Mice: The Role of BDNF-mTOR Signaling Pathway.

  2018cites this paper
• Neuroprotective Effects of Nicotine on Hippocampal Long-Term Potentiation in Brain Disorders

  2018cites this paper
• Bidirectional Regulation of Mouse Embryonic Stem Cell Proliferation by Nicotine Is Mediated Through Wnt Signaling Pathway

  2017cites this paper
• Streptozotocin induces cognitive impairment in rats ∗∗∗∗

  year unknowncites this paper